Polydopamine-Lysophosphatidate-Functionalised Titanium: A Novel Hybrid Surface Finish for Bone Regenerative...

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Surface Chemistry

Background:

• Aseptic loosening is the primary cause of total joint replacement failure, leading to significant socioeconomic costs due to revision surgeries.
• Enhancing the longevity of titanium implants is crucial for reducing revision rates and healthcare expenditure.
• Polydopamine thin films show promise for biomaterial surface functionalization.

Purpose of the Study:

• To develop a superior titanium surface technology to improve implant longevity.
• To investigate the efficacy of a novel surface modification using dopamine hydrochloride and a lysophosphatidic acid analogue.

Main Methods:

• Medical-grade titanium was immersed in a dopamine hydrochloride and (3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate solution.
• The modified titanium surface was analyzed for its ability to enhance osteoblast maturation.

Main Results:

• The "one-pot" surface modification using dopamine hydrochloride and FHBP (DHC-FHBP) significantly enhanced osteoblast maturation compared to titanium treated with FHBP alone.
• This facile surface modification strategy yielded a superior biological performance.

Conclusions:

• The DHC-FHBP surface modification offers a promising strategy for improving titanium implant osseointegration and longevity.
• This approach may reduce the incidence and cost of revision arthroplasties.
• The simplicity and biological efficacy make this modified titanium surface attractive for future implant applications.